Publications by authors named "Tardos L"

The nigrostriatal system, where dopaminergic neuron activity dominates, plays and important role in control of motoric and psychic functions. Selegiline with its neurochemical activity ie. MAO-B enzyme and dopamine uptake inhibition is able to restore or improve the deteriorated function of that system.

View Article and Find Full Text PDF

Pentoxifylline is an orally active agent for the treatment of peripherial and cerebral vascular diseases. Pentoxifylline increases the deformability of red blood cells in vitro, reduces blood viscosity and decreases platelet aggregation and thrombus formation. Depogen has shown antiaggregatory effect both in vitro and in ex vivo.

View Article and Find Full Text PDF

GYKI-32 887 reveals an antihypertensive action, similar to that of the known ergoline derivatives, in conscious SH-rats, in anesthetized normotensive rats, and in cats. It exerts its action first of all by stimulation of the central DA-receptors and by this it reduces the sympathetic activity. The hypotensive effect cannot be detected after icv administration, but both the hypotension and bradycardia can be antagonized by sulpiride administered either icv or iv.

View Article and Find Full Text PDF

The cardiovascular effects of morphine and a potent enkephalin analogue, D-Met2, Pro5-enkephalinamide (D-Met2, Pro5-EA) have been examined in pentobarbitone anesthetized cats with their vagi cut and in awake normotensive and genetically hypertensive rats. In cats both opioids only moderately decreased the blood pressure and the heart rate, but the enkephalin analogue considerably attenuated the carotid occlusion pressor response. Neither substance influenced the blood pressure and the heart rate in normotensive rats, but both induced moderate hypotension and considerable bradycardia in spontaneously hypertensive rats, the potency of D-Met2, Pro5-EA being much stronger than that of morphine.

View Article and Find Full Text PDF